W.W. Grainger First Quarter 2025 Earnings: EPS Beats Expectations

Simply Wall St

May 06, 2025

W.W. Grainger (NYSE:GWW) First Quarter 2025 Results

Key Financial Results

Revenue: US$4.31b (up 1.7% from 1Q 2024).
Net income: US$479.0m (flat on 1Q 2024).
Profit margin: 11% (in line with 1Q 2024).
EPS: US$9.94 (up from US$9.72 in 1Q 2024).

AI is about to change healthcare. These 20 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10bn in marketcap - there is still time to get in early.

earnings-and-revenue-growth — NYSE:GWW Earnings and Revenue Growth May 6th 2025

All figures shown in the chart above are for the trailing 12 month (TTM) period

W.W. Grainger EPS Beats Expectations

Revenue was in line with analyst estimates. Earnings per share (EPS) surpassed analyst estimates by 4.0%.

Looking ahead, revenue is forecast to grow 6.2% p.a. on average during the next 3 years, compared to a 6.2% growth forecast for the Trade Distributors industry in the US.

Performance of the American Trade Distributors industry.

The company's shares are up 5.3% from a week ago.

Valuation

Our analysis of W.W. Grainger based on 6 different valuation metrics shows it might be overvalued. To explore our complete evaluation click here and get an understanding of what analysts are thinking about the company's future.

If you're looking to trade W.W. Grainger, open an account with the lowest-cost platform trusted by professionals, Interactive Brokers.

With clients in over 200 countries and territories, and access to 160 markets, IBKR lets you trade stocks, options, futures, forex, bonds and funds from a single integrated account.

Enjoy no hidden fees, no account minimums, and FX conversion rates as low as 0.03%, far better than what most brokers offer.

Valuation is complex, but we're here to simplify it.

Discover if W.W. Grainger might be undervalued or overvalued with our detailed analysis, featuring fair value estimates, potential risks, dividends, insider trades, and its financial condition.

Access Free Analysis

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.